{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:04:15Z","timestamp":1773795855856,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100010221","name":"Higher Education Commision, Pakistan","doi-asserted-by":"publisher","award":["NRPU 6671\/KP\/NRPU\/R&D\/HEC\/2016"],"award-info":[{"award-number":["NRPU 6671\/KP\/NRPU\/R&D\/HEC\/2016"]}],"id":[{"id":"10.13039\/501100010221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11033-020-05997-0","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T16:03:00Z","timestamp":1605801780000},"page":"9553-9566","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Synthetic \u03b2-hydroxy ketone derivative inhibits cholinesterases, rescues oxidative stress and ameliorates cognitive deficits in 5XFAD mice model of AD"],"prefix":"10.1007","volume":"47","author":[{"given":"Syed Ilyas","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9749-0645","authenticated-orcid":false,"given":"Gowhar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5819-1397","authenticated-orcid":false,"given":"Tahir","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahim","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Naveed","family":"Umar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha Nasir","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"issue":"18","key":"5997_CR1","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1001\/jama.287.18.2335","volume":"287","author":"JL Cummings","year":"2002","unstructured":"Cummings JL, Cole G (2002) Alzheimer disease. JAMA 287(18):2335\u20132338. https:\/\/doi.org\/10.1001\/jama.287.18.2335","journal-title":"JAMA"},{"issue":"3","key":"5997_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","volume":"3","author":"R Brookmeyer","year":"2007","unstructured":"Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 3(3):186\u2013191. https:\/\/doi.org\/10.1016\/j.jalz.2007.04.381","journal-title":"Alzheimer's Dementia"},{"issue":"4","key":"5997_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","volume":"11","author":"FM LaFerla","year":"2005","unstructured":"LaFerla FM, Oddo S (2005) Alzheimer\u2019s disease: A\u03b2, tau and synaptic dysfunction. Trends Mol Med 11(4):170\u2013176. https:\/\/doi.org\/10.1016\/j.molmed.2005.02.009","journal-title":"Trends Mol Med"},{"issue":"6","key":"5997_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16(6):358. https:\/\/doi.org\/10.1038\/nrn3880","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"5997_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1212\/wnl.39.3.355","volume":"39","author":"JE Hamos","year":"1989","unstructured":"Hamos JE, DeGennaro LJ, Drachman DA (1989) Synaptic loss in Alzheimer\u2019s disease and other dementias. Neurology 39(3):355\u2013355. https:\/\/doi.org\/10.1212\/wnl.39.3.355","journal-title":"Neurology"},{"issue":"1","key":"5997_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000464422","volume":"24","author":"A Sanabria-Castro","year":"2017","unstructured":"Sanabria-Castro A, Alvarado-Echeverr\u00eda I, Monge-Bonilla C (2017) Molecular pathogenesis of Alzheimer\u2019s disease: an update. Ann Neurosci 24(1):46\u201354. https:\/\/doi.org\/10.1159\/000464422","journal-title":"Ann Neurosci"},{"issue":"2","key":"5997_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","volume":"67","author":"A Kumar","year":"2015","unstructured":"Kumar A, Singh A (2015) A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacol Rep 67(2):195\u2013203. https:\/\/doi.org\/10.1016\/j.pharep.2014.09.004","journal-title":"Pharmacol Rep"},{"issue":"2","key":"5997_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1517\/14728222.11.2.161","volume":"11","author":"U Holzgrabe","year":"2007","unstructured":"Holzgrabe U, Kapkov\u00e1 P, Alpt\u00fcz\u00fcn V, Scheiber J, Kugelmann E (2007) Targeting acetylcholinesterase to treat neurodegeneration. Expert Opin Ther Targets 11(2):161\u2013179. https:\/\/doi.org\/10.1517\/14728222.11.2.161","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"5997_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s11481-018-9824-3","volume":"14","author":"T Muhammad","year":"2019","unstructured":"Muhammad T, Ali T, Ikram M, Khan A, Alam SI, Kim MO (2019) Melatonin rescue oxidative stress-mediated neuroinflammation\/neurodegeneration and memory impairment in scopolamine-induced amnesia mice model. J Neuroimmune Pharmacol 14(2):278\u2013294. https:\/\/doi.org\/10.1007\/s11481-018-9824-3","journal-title":"J Neuroimmune Pharmacol"},{"issue":"5","key":"5997_CR10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/jcm8050680","volume":"8","author":"A Khan","year":"2019","unstructured":"Khan A, Ikram M, Muhammad T, Park J, Kim MO (2019) Caffeine modulates cadmium-induced oxidative stress, neuroinflammation, and cognitive impairments by regulating Nrf-2\/HO-1 in vivo and in vitro. J Clin Med 8(5):680. https:\/\/doi.org\/10.3390\/jcm8050680","journal-title":"J Clin Med"},{"issue":"9","key":"5997_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/s1474-4422(03)00502-7","volume":"2","author":"P Schelterns","year":"2003","unstructured":"Schelterns P, Feldman H (2003) Treatment of Alzheimer\u2019s disease; current status and new perspectives. Lancet Neurol 2(9):539\u2013547. https:\/\/doi.org\/10.1016\/s1474-4422(03)00502-7","journal-title":"Lancet Neurol"},{"issue":"14","key":"5997_CR12","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa013128","volume":"348","author":"B Reisberg","year":"2003","unstructured":"Reisberg B, Doody R, St\u00f6ffler A, Schmitt F, Ferris S, M\u00f6bius HJ (2003) Memantine in moderate-to-severe Alzheimer\u2019s disease. N Engl J Med 348(14):1333\u20131341. https:\/\/doi.org\/10.1056\/NEJMoa013128","journal-title":"N Engl J Med"},{"issue":"S1","key":"5997_CR13","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1002\/gps.938","volume":"18","author":"W Danysz","year":"2003","unstructured":"Danysz W, Parsons CG (2003) The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer\u2019s disease: preclinical evidence. Int J Geriatric Psychiatry 18(S1):S23\u2013S32. https:\/\/doi.org\/10.1002\/gps.938","journal-title":"Int J Geriatric Psychiatry"},{"issue":"6","key":"5997_CR14","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148(6):1204\u20131222. https:\/\/doi.org\/10.1016\/j.cell.2012.02.040","journal-title":"Cell"},{"issue":"7","key":"5997_CR15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","volume":"9","author":"F Mangialasche","year":"2010","unstructured":"Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M (2010) Alzheimer\u2019s disease: clinical trials and drug development. Lancet Neurol 9(7):702\u2013716. https:\/\/doi.org\/10.1016\/S1474-4422(10)70119-8","journal-title":"Lancet Neurol"},{"issue":"5","key":"5997_CR16","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1039\/B923537J","volume":"39","author":"BM Trost","year":"2010","unstructured":"Trost BM, Brindle CS (2010) The direct catalytic asymmetric aldol reaction. Chem Soc Rev 39(5):1600\u20131632. https:\/\/doi.org\/10.1039\/B923537J","journal-title":"Chem Soc Rev"},{"issue":"8","key":"5997_CR17","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1021\/jo048410j","volume":"16","author":"JM Padr\u00f3n","year":"2006","unstructured":"Padr\u00f3n JM, Miranda PO, Padr\u00f3n JI, Mart\u00edn VS (2006) \u03b2\u2032-Hydroxy-\u03b1, \u03b2-unsaturated ketones: a new pharmacophore for the design of anticancer drugs. Bioorg Med Chem Lett 16(8):2266\u20132269. https:\/\/doi.org\/10.1021\/jo048410j","journal-title":"Bioorg Med Chem Lett"},{"issue":"16","key":"5997_CR18","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1080\/00397911.2016.1206938","volume":"46","author":"S Mandal","year":"2016","unstructured":"Mandal S, Mandal S, Ghosh SK, Ghosh A, Saha R, Banerjee S, Saha B (2016) Review of the aldol reaction. Synth Commun 46(16):1327\u20131342. https:\/\/doi.org\/10.1080\/00397911.2016.1206938","journal-title":"Synth Commun"},{"issue":"6","key":"5997_CR19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1179\/1743132812Y.0000000054","volume":"34","author":"T Kurata","year":"2012","unstructured":"Kurata T, Miyazaki K, Kozuki M, Morimoto N, Ohta Y, Ikeda Y, Abe K (2012) Atorvastatin and pitavastatin reduce senile plaques and inflammatory responses in a mouse model of Alzheimer\u2019s disease. Neurol Res 34(6):601\u2013610. https:\/\/doi.org\/10.1179\/1743132812Y.0000000054","journal-title":"Neurol Res"},{"key":"5997_CR20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3389\/fphar.2017.00697","volume":"8","author":"M Ayaz","year":"2017","unstructured":"Ayaz M, Junaid M, Ullah F, Subhan F, Sadiq A, Ali G, Ovais M, Shahid M, Ahmad A, Wadood A (2017) Anti-Alzheimer\u2019s studies on \u03b2-sitosterol isolated from Polygonum hydropiper L. Front Pharmacol 8:697. https:\/\/doi.org\/10.3389\/fphar.2017.00697","journal-title":"Front Pharmacol"},{"issue":"2","key":"5997_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V Jr, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7(2):88\u201395. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"5997_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40659-015-0011-1","volume":"48","author":"Z Kamal","year":"2015","unstructured":"Kamal Z, Ullah F, Ayaz M, Sadiq A, Ahmad S, Zeb A, Hussain A, Imran M (2015) Anticholinesterse and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of Atriplex laciniata L.: potential effectiveness in Alzheimer\u2019s and other neurological disorders. Biol Res 48(1):21. https:\/\/doi.org\/10.1186\/s40659-015-0011-1","journal-title":"Biol Res"},{"key":"5997_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"M Brasford","year":"1976","unstructured":"Brasford M (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254. https:\/\/doi.org\/10.1016\/0003-2697(76)90527-3","journal-title":"Anal Biochem"},{"issue":"7","key":"5997_CR24","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1021\/np0100845","volume":"64","author":"A Braca","year":"2001","unstructured":"Braca A, De Tommasi N, Di Bari L, Pizza C, Politi M, Morelli I (2001) Antioxidant principles from bauhinia t arapotensis. J Nat Prod 64(7):892\u2013895. https:\/\/doi.org\/10.1021\/np0100845","journal-title":"J Nat Prod"},{"key":"5997_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nlm.2013.10.015","volume":"107","author":"T Petrasek","year":"2014","unstructured":"Petrasek T, Prokopova I, Bahnik S, Schonig K, Berger S, Vales K, Tews B, Schwab ME, Bartsch D, Stuchlik A (2014) Nogo-A downregulation impairs place avoidance in the Carousel maze but not spatial memory in the Morris water maze. Neurobiol Learn Mem 107:42\u201349. https:\/\/doi.org\/10.1016\/j.nlm.2013.10.015","journal-title":"Neurobiol Learn Mem"},{"key":"5997_CR26","doi-asserted-by":"publisher","first-page":"e2608","DOI":"10.3791\/2608","volume":"76","author":"RM Deacon","year":"2013","unstructured":"Deacon RM (2013) Shallow water (paddling) variants of water maze tests in mice. J Vis Exp 76:e2608. https:\/\/doi.org\/10.3791\/2608","journal-title":"J Vis Exp"},{"issue":"2","key":"5997_CR27","first-page":"206","volume":"3","author":"PD Kulkarni","year":"2011","unstructured":"Kulkarni PD, Ghaisas MM, Chivate ND, Sankpal PS (2011) Memory enhancing activity of Cissampelos pariera in mice. Int J Pharm Pharm Sci 3(2):206\u2013211","journal-title":"Int J Pharm Pharm Sci"},{"issue":"6","key":"5997_CR28","first-page":"2067","volume":"30","author":"M Shahid","year":"2017","unstructured":"Shahid M, Subhan F, Ali G, Ullah I, Alam J, Ullah S, Rauf K (2017) Neuroprotective effect of Bacopa monnieri against morphine-induced histopathological changes in the cerebellum of rats. Pakistan J Pharm Sci 30(6):2067\u20132074","journal-title":"Pakistan J Pharm Sci"},{"key":"5997_CR29","doi-asserted-by":"publisher","first-page":"e2831","DOI":"10.3791\/2831","volume":"53","author":"PT Ly","year":"2011","unstructured":"Ly PT, Cai F, Song W (2011) Detection of neuritic plaques in Alzheimer\u2019s disease mouse model. J Vis Exp 53:e2831. https:\/\/doi.org\/10.3791\/2831","journal-title":"J Vis Exp"},{"issue":"3","key":"5997_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/sj.mp.4000383","volume":"3","author":"F Calderon","year":"1998","unstructured":"Calderon F, Von Bernhardi R, De Ferrari G, Luza S, Aldunate R, Inestrosa N (1998) Toxic effects of acetylcholinesterase on neuronal and glial-like cells in vitro. Mol Psychiatry 3(3):247\u2013255. https:\/\/doi.org\/10.1038\/sj.mp.4000383","journal-title":"Mol Psychiatry"},{"issue":"2","key":"5997_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","volume":"66","author":"PT Francis","year":"1999","unstructured":"Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress. J Neurol Neurosurg Psychiatry 66(2):137\u2013147. https:\/\/doi.org\/10.1136\/jnnp.66.2.137","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"5997_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000047952","volume":"47","author":"C Ballard","year":"2002","unstructured":"Ballard C (2002) Advances in the treatment of Alzheimer\u2019s disease: benefits of dual cholinesterase inhibition. Eur Neurol 47(1):64\u201370. https:\/\/doi.org\/10.1159\/000047952","journal-title":"Eur Neurol"},{"issue":"4537","key":"5997_CR33","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.7058341","volume":"215","author":"PJ Whitehouse","year":"1982","unstructured":"Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR (1982) Alzheimer\u2019s disease and senile dementia: loss of neurons in the basal forebrain. Science 215(4537):1237\u20131239. https:\/\/doi.org\/10.1126\/science.7058341","journal-title":"Science"},{"issue":"4","key":"5997_CR34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1177\/026988110001400410","volume":"14","author":"N Dunn","year":"2000","unstructured":"Dunn N, Pearce G, Shakir S (2000) Adverse effects associated with the use of donepezil in general practice in England. J Psychopharmacol 14(4):406\u2013408. https:\/\/doi.org\/10.1177\/026988110001400410","journal-title":"J Psychopharmacol"},{"issue":"3","key":"5997_CR35","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.neuropharm.2006.04.007","volume":"51","author":"Y Takada-Takatori","year":"2006","unstructured":"Takada-Takatori Y, Kume T, Sugimoto M, Katsuki H, Sugimoto H, Akaike A (2006) Acetylcholinesterase inhibitors used in treatment of Alzheimer\u2019s disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade. Neuropharmacology 51(3):474\u2013486. https:\/\/doi.org\/10.1016\/j.neuropharm.2006.04.007","journal-title":"Neuropharmacology"},{"issue":"3","key":"5997_CR36","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/nu11030648","volume":"11","author":"T Muhammad","year":"2019","unstructured":"Muhammad T, Ikram M, Ullah R, Rehman SU, Kim MO (2019) Hesperetin, a citrus flavonoid, attenuates LPS-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4\/NF-\u03baB signaling. Nutrients 11(3):648. https:\/\/doi.org\/10.3390\/nu11030648","journal-title":"Nutrients"},{"key":"5997_CR37","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3389\/fphar.2018.01383","volume":"9","author":"A Khan","year":"2018","unstructured":"Khan A, Ali T, Rehman SU, Khan MS, Alam SI, Ikram M, Muhammad T, Saeed K, Badshah H, Kim MO (2018) Neuroprotective effect of quercetin against the detrimental effects of LPS in the adult mouse brain. Front Pharmacol 9:1383. https:\/\/doi.org\/10.3389\/fphar.2018.01383","journal-title":"Front Pharmacol"},{"issue":"5","key":"5997_CR38","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3390\/nu11051082","volume":"11","author":"M Ikram","year":"2019","unstructured":"Ikram M, Saeed K, Khan A, Muhammad T, Khan MS, Jo MG, Rehman SU, Kim MO (2019) Natural dietary supplementation of curcumin protects mice brains against ethanol-induced oxidative stress-mediated neurodegeneration and memory impairment via Nrf2\/TLR4\/RAGE signaling. Nutrients 11(5):1082. https:\/\/doi.org\/10.3390\/nu11051082","journal-title":"Nutrients"},{"key":"5997_CR39","doi-asserted-by":"publisher","first-page":"7860650","DOI":"10.1155\/2019\/7860650","volume":"2019","author":"MS Khan","year":"2019","unstructured":"Khan MS, Muhammad T, Ikram M, Kim MO (2019) Dietary supplementation of the antioxidant curcumin halts systemic LPS-induced neuroinflammation-associated neurodegeneration and memory\/synaptic impairment via the JNK\/NF-kappaB\/Akt signaling pathway in adult rats. Oxid Med Cell Longev 2019:7860650. https:\/\/doi.org\/10.1155\/2019\/7860650","journal-title":"Oxid Med Cell Longev"},{"key":"5997_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.07.005","volume":"147","author":"T Jiang","year":"2016","unstructured":"Jiang T, Sun Q, Chen S (2016) Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson\u2019s disease and Alzheimer\u2019s disease. Prog Neurobiol 147:1\u201319. https:\/\/doi.org\/10.1016\/j.pneurobio.2016.07.005","journal-title":"Prog Neurobiol"},{"issue":"1","key":"5997_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s0925-4439(00)00040-5","volume":"1502","author":"MA Smith","year":"2000","unstructured":"Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G (2000) Oxidative stress in Alzheimer\u2019s disease. Biochimica et Biophysica Acta (BBA) 1502(1):139\u2013144. https:\/\/doi.org\/10.1016\/s0925-4439(00)00040-5","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"3","key":"5997_CR42","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.neulet.2009.11.010","volume":"468","author":"B Su","year":"2010","unstructured":"Su B, Wang X, Lee H-g, Tabaton M, Perry G, Smith MA, Zhu X (2010) Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells. Neurosci Lett 468(3):267\u2013271. https:\/\/doi.org\/10.1016\/j.neulet.2009.11.010","journal-title":"Neurosci Lett"},{"issue":"5580","key":"5997_CR43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356. https:\/\/doi.org\/10.1126\/science.1072994","journal-title":"Science"},{"issue":"5054","key":"5997_CR44","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256(5054):184\u2013186. https:\/\/doi.org\/10.1126\/science.1566067","journal-title":"Science"},{"issue":"12","key":"5997_CR45","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","volume":"283","author":"J N\u00e4slund","year":"2000","unstructured":"N\u00e4slund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD (2000) Correlation between elevated levels of amyloid \u03b2-peptide in the brain and cognitive decline. JAMA 283(12):1571\u20131577. https:\/\/doi.org\/10.1001\/jama.283.12.1571","journal-title":"JAMA"},{"issue":"6815","key":"5997_CR46","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1023\/A:1023255106106","volume":"408","author":"G Chen","year":"2000","unstructured":"Chen G, Chen KS, Knox J, Inglis J, Bernard A, Martin SJ, Justice A, McConlogue L, Games D, Freedman SB (2000) A learning deficit related to age and \u03b2-amyloid plaques in a mouse model of Alzheimer\u2019s disease. Nature 408(6815):975. https:\/\/doi.org\/10.1023\/A:1023255106106","journal-title":"Nature"},{"issue":"1","key":"5997_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(85)90160-5","volume":"14","author":"T Arendt","year":"1985","unstructured":"Arendt T, Bigl V, Tennstedt A, Arendt A (1985) Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer\u2019s disease. Neuroscience 14(1):1\u201314. https:\/\/doi.org\/10.1016\/0306-4522(85)90160-5","journal-title":"Neuroscience"},{"issue":"8","key":"5997_CR48","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3390\/cells8080928","volume":"8","author":"M Khan","year":"2019","unstructured":"Khan M, Ullah R, Rehman SU, Shah SA, Saeed K, Muhammad T, Park HY, Jo MH, Choe K, Rutten BPF, Kim MO (2019) 17beta-estradiol modulates SIRT1 and halts oxidative stress-mediated cognitive impairment in a male aging mouse model. Cells 8(8):928. https:\/\/doi.org\/10.3390\/cells8080928","journal-title":"Cells"},{"issue":"1","key":"5997_CR49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/s0165-0173(01)00067-4","volume":"36","author":"R D\u2019Hooge","year":"2001","unstructured":"D\u2019Hooge R, De Deyn PP (2001) Applications of the Morris water maze in the study of learning and memory. Brain Res Rev 36(1):60\u201390. https:\/\/doi.org\/10.1016\/s0165-0173(01)00067-4","journal-title":"Brain Res Rev"},{"issue":"4","key":"5997_CR50","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/geronj\/42.4.412","volume":"42","author":"JC Morris","year":"1987","unstructured":"Morris JC, Rubin EH, Morris EJ, Mandel SA (1987) Senile dementia of the Alzheimer\u2019s type: an important risk factor for serious falls. J Gerontol 42(4):412\u2013417. https:\/\/doi.org\/10.1093\/geronj\/42.4.412","journal-title":"J Gerontol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05997-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-020-05997-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05997-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T10:20:51Z","timestamp":1607422851000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-020-05997-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5997"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05997-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was carried out under the project title as Novel targeted heterocyclic compounds, a potential candidate for Alzheimer's disease\u2019 approved by the Research Ethical Committee of Pharmacy Department, University of Peshawar, Pakistan has been approved all experimental procedures on animals vide reference number 25\/EC-18\/Pharm, dated. 16\/10\/2018.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}